Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshimichi Asano

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Cancer Science|April 19, 2019
Prognostic relevance of tertiary lymphoid organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarcinomaShota Kuwabara, Takahiro Tsuchikawa, Toru Nakamura, et al.
Oncology Reports|December 23, 2022
Identification of antibody against wingless‑type MMTV integration site family member 7B as a biliary cancer tumor markerMizuna Takahashi, Takahiro Tsuchikawa, Takaki Hiwasa, et al.
Annals of Surgical Oncology|December 5, 2023
Impact of Neutrophil Extracellular Traps Identified by Citrullinated Histone H3 Immunohistochemistry for Postoperative Prognosis in Patients with Extrahepatic CholangiocarcinomasHiroyuki Yamamoto, Yoshitsugu Nakanishi, Tomoko Mitsuhashi, et al.
Molecular Cancer Therapeutics|October 11, 2019
Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic TargetToshihiro Kushibiki, Toru Nakamura, Masumi Tsuda, et al.
Cancers|March 29, 2023
CCR7 Mediates Cell Invasion and Migration in Extrahepatic Cholangiocarcinoma by Inducing Epithelial-Mesenchymal TransitionMitsunobu Oba, Yoshitsugu Nakanishi, Tomoko Mitsuhashi, et al.
Annals of Surgical Oncology|April 11, 2022
Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scoring in Combination with CA19-9Masato Ono, Yusuke Ono, Toru Nakamura, et al.
Eclinicalmedicine|January 7, 2025
A noninvasive urinary microRNA-based assay for the detection of pancreatic cancer from early to late stages: a case control studyShogo Baba, Tadatoshi Kawasaki, Satoshi Hirano, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|January 7, 2026
Survival Impact After Resection for Postoperative Recurrence or Metastasis of Pancreatic Ductal Adenocarcinoma Analyzed Using a Time-Dependent Cox Regression ModelDenys Tsybulskyi, Daisuke Hashimoto, Kimitaka Tanaka, et al.
Annals of Gastroenterological Surgery|July 3, 2025
Clinical role of intraperitoneal chemotherapy in patients with pancreatic ductal adenocarcinoma concomitant with occult peritoneal dissemination: A multicenter retrospective studyTomohisa Yamamoto, Toshio Shimokawa, Masamichi Hayashi, et al.
Journal of Gastroenterology|May 4, 2026
Conversion surgery for unresectable pancreatic ductal adenocarcinoma with liver metastasis at initial diagnosis: a nationwide multicenter studyDaisuke Hashimoto, Tsukasa Ikeura, Aya Maekawa, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Cancer Science|April 19, 2019
Prognostic relevance of tertiary lymphoid organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarcinomaShota Kuwabara, Takahiro Tsuchikawa, Toru Nakamura, et al.
Oncology Reports|December 23, 2022
Identification of antibody against wingless‑type MMTV integration site family member 7B as a biliary cancer tumor markerMizuna Takahashi, Takahiro Tsuchikawa, Takaki Hiwasa, et al.
Annals of Surgical Oncology|December 5, 2023
Impact of Neutrophil Extracellular Traps Identified by Citrullinated Histone H3 Immunohistochemistry for Postoperative Prognosis in Patients with Extrahepatic CholangiocarcinomasHiroyuki Yamamoto, Yoshitsugu Nakanishi, Tomoko Mitsuhashi, et al.
Molecular Cancer Therapeutics|October 11, 2019
Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic TargetToshihiro Kushibiki, Toru Nakamura, Masumi Tsuda, et al.
Cancers|March 29, 2023
CCR7 Mediates Cell Invasion and Migration in Extrahepatic Cholangiocarcinoma by Inducing Epithelial-Mesenchymal TransitionMitsunobu Oba, Yoshitsugu Nakanishi, Tomoko Mitsuhashi, et al.
Annals of Surgical Oncology|April 11, 2022
Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scoring in Combination with CA19-9Masato Ono, Yusuke Ono, Toru Nakamura, et al.
Eclinicalmedicine|January 7, 2025
A noninvasive urinary microRNA-based assay for the detection of pancreatic cancer from early to late stages: a case control studyShogo Baba, Tadatoshi Kawasaki, Satoshi Hirano, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|January 7, 2026
Survival Impact After Resection for Postoperative Recurrence or Metastasis of Pancreatic Ductal Adenocarcinoma Analyzed Using a Time-Dependent Cox Regression ModelDenys Tsybulskyi, Daisuke Hashimoto, Kimitaka Tanaka, et al.
Annals of Gastroenterological Surgery|July 3, 2025
Clinical role of intraperitoneal chemotherapy in patients with pancreatic ductal adenocarcinoma concomitant with occult peritoneal dissemination: A multicenter retrospective studyTomohisa Yamamoto, Toshio Shimokawa, Masamichi Hayashi, et al.
Journal of Gastroenterology|May 4, 2026
Conversion surgery for unresectable pancreatic ductal adenocarcinoma with liver metastasis at initial diagnosis: a nationwide multicenter studyDaisuke Hashimoto, Tsukasa Ikeura, Aya Maekawa, et al.
Pageof 9